TS-062229 — The Need Avian pathogenic Escherichia coli (APEC) and Salmonella infections in poultry pose a significant commercial and health challenge. Current treatments relying on antimicrobial drugs have limited effectiveness and contribute to the emergence of antibiotic-resistant strains, exacerbating the p…

TS-062219 — The Need: Addressing the Global Threat of Necrotic Enteritis in Poultry Necrotic enteritis (NE) poses a significant commercial challenge to the poultry industry, with estimated annual costs reaching up to 5-6 billion USD worldwide. The disease, caused by Clostridium perfringens, affects broilers, l…

TS-060542 — The Problem Swine influenza is an acute respiratory disease of pigs caused by swine influenza A virus (SwIAV). Pigs are naturally vulnerable to SwIAV-associated with secondary bacterial infections and is an economic threat to the global pig industry. Commonly circulating SwIAV strains in swine popu…

TS-052320 — The Need Avian pathogenic Escherichia coli (APEC) and Salmonella infections in poultry pose a significant commercial and health challenge. Current treatments relying on antimicrobial drugs have limited effectiveness and contribute to the emergence of antibiotic-resistant strains, exacerbating the p…

TS-044474 — The Need Foodborne illnesses caused by bacterial pathogens like Campylobacter pose a significant public health concern worldwide, leading to millions of illnesses and thousands of deaths each year. Increasing bacterial resistance to antibiotics is creating an urgent need for new and novel antibioti…

TS-040540 — The Need Avian Pathogenic E. coli (APEC) poses a significant threat to the poultry industry worldwide, causing severe economic losses due to increased mortality, decreased growth rate of infected birds, and rendering large parts of the entire bird useless for sale. Additionally, APEC is suspected t…

TS-039567 — The Need The increasing incidence of bacterial driven foodborne illnesses poses a significant public health risk and economic burden worldwide. Conventional antimicrobial treatments have become less effective, and the development of novel, targeted solutions is essential to combat these pathogens a…